CURRENT LOCATION:
HOME》Technology transfer》Chemical technology transfer》Generic transfer》Cinacalcet
Cinacalcet

    Project NameCinacalcet 

    Registration Classification:3+6

    Formulations and specifications Tablets, 30mg 

    IndicationsFor the treatment of secondary hyperparathyroidism in kidney dialysis with hyperthyroidism , or hypercalcemia due to parathyroid carcinoma .

    Original Research CompanyAMGEN (UK Amgen) 

    Progress Synthesis process has been completed 

     

Links:

地址:北京市丰台区造甲街南里5号4A楼2层
电话:010-63716441 63717341 传真:010-63728443
COPYRIGHT (C) 2014 Beijing Mega Pharmaceutical Science and Technology Co.,ltd. ALL RIGHTS RESERVED
版权所有 北京满格医药科技有限公司 京ICP备12000952号